Friday, January 21, 2022
This conference has already taken place.
Description
data is practice changing and needs to be incorporated into clinical practice. The target audience does not have the time needed to attend the meeting and to analyze the large amount of
data presented and therefore is unable to incorporate new discoveries and recent changes in treatments presented during the national ASH meeting to their clinical practice. Due to these issues,
the target audience is not able to stay up to date.
For pricing information, see pricing tab below.
Dates and Times
Start: 1/21/2022 12:00 AM
End: 1/21/2022 12:00 AM
Objectives
- Identify strategies to incorporate the latest treatment information on an array of hematologic disease into clinical practice.
- Employ the knowledge gained regarding the diagnosis and treatment of benign and malignant hematologic disorders to improve patient care.
- To describe state-of-the-art research in hematology.
- To illustrate the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of hematologic disorders.
- Explain the efficacy and role of CAR-T cell therapy in lymphoma and myeloma.
- Identify the emerging role of immunotherapy in multiple myeloma.
- Evaluate current strategy of treatment for acute and chronic leukemias.
- Identify the advances in the management of sickle cell anemia and other benign hematological diseases
- Formulate the current clinical practice guidelines on stem cell transplantation.
Pricing
| Tier | Price |
|---|---|
| The is a free event | $0.00 |
Conference Files
| File | Link |
|---|---|
|
Agenda Click Download to View |
Download |
Speakers
Location
The Fawcett Center
2400 Olentangy River Rd
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.